Topics

Analysis: FDA's efforts to speed drug approval may have led to less rigorous clinical outcome requirements https://www.firstwordpharma.com/node/1693833 

05:36 EST 15 Jan 2020 | FirstWord Pharma

Analysis: FDA's efforts to speed drug approval may have led to less rigorous clinical outcome requirements https://www.firstwordpharma.com/node/1693833 

Original Article: Analysis: FDA's efforts to speed drug approval may have led to less rigorous clinical outcome requirements https://www.firstwordpharma.com/node/1693833 

NEXT ARTICLE

More From BioPortfolio on "Analysis: FDA's efforts to speed drug approval may have led to less rigorous clinical outcome requirements https://www.firstwordpharma.com/node/1693833 "

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...